Deletion of hemojuvelin, an iron-regulatory protein, in mice results in abnormal angiogenesis and vasculogenesis in retina along with reactive gliosis

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 6, 2014, Pages 3616-3625

  Tawfik, Amany ^a   Gnana Prakasam, Jaya P ^a   Smith, Sylvia B ^a   Ganapathy, Vadivel ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Angiogenesis; Gliosis; Iron; Retinal vasculature

Indexed keywords

CD11B ANTIGEN; COLLAGEN TYPE 4; ENDOGLIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOPROTEIN P 15095; HEMOJUVELIN; IRON REGULATORY FACTOR; ISOLECTIN B4; TRYPSIN; VASCULOTROPIN; VIMENTIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BLOOD RETINA BARRIER; CONTROLLED STUDY; EPIFLUORESCENCE MICROSCOPY; FLUORESCENCE MICROSCOPY; GENE DELETION; GENOTYPING TECHNIQUE; GLIOSIS; HEMOCHROMATOSIS; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MICROGLIA; MOUSE; MUELLER CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA; RETINA FLUORESCEIN ANGIOGRAPHY; VASCULARIZATION;

ANGIOGENESIS; GLIOSIS; IRON; RETINAL VASCULATURE;

ANIMALS; DISEASE MODELS, ANIMAL; DNA; DNA MUTATIONAL ANALYSIS; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; GENE DELETION; GLIOSIS; IRON; IRON-REGULATORY PROTEINS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NEUROGLIA; RETINA; RETINAL NEOVASCULARIZATION; RETINAL VESSELS;

EID: 84902449592     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-13677     Document Type: Article

References (50)

1. Babitt JL, Lin HY. The molecular pathogenesis of hereditary hemochromatosis. Semin Liver Dis. 2011;31:280-292.
2. Pietrangelo A, Caleffi A, Corradini E. Non-HFE hepatic iron overload. Semin Liver Dis. 2011;31:302-318.
3. Kaplan J, Ward DM, De Domenico I. The molecular basis of iron overload disorders and iron-linked anemias. Int J Hematol. 2011;93:14-20.
4. Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta. 2012;1823:1434-1443.
5. Gnana-Prakasam JP, Thangaraju M, Liu K, et al. Absence of ironregulatory protein Hfe results in hyperproliferation of retinal pigment epithelium: role of cystine/glutamate exchanger. Biochem J. 2009;424:243-252.
6. Gnana-Prakasam JP, Ananth S, Prasad PD, et al. Expression and iron-dependent regulation of succinate receptor GPR91 in retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2011; 52:3751-3758.
7. Gnana-Prakasam J, Tawfik A, Romej M, et al. Iron-mediated retinal degeneration in hemojuvelin knockout mice. Biochem J. 2012;441:599-608.
8. Gnana-Prakasam JP, Veeranan-Karmegam R, Coothankandaswamy V, et al. Loss of Hfe leads to progression of tumor phenotype in primary retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2013;54:63-71.
9. Gnana-Prakasam JP, Reddy SK, Veeranan-Karmegam R, Smith SB, Martin PM, Ganapathy V. Polarized distribution of heme transporters in retinal pigment epithelium and their regulation in the iron-overload disease hemochromatosis. Invest Ophthalmol Vis Sci. 2011;52:9279-9286.
10. Hadziahmetovic M, Song Y, Ponnuru P, et al. Age-dependent retinal iron accumulation and degeneration in hepcidin knockout mice. Invest Ophthalmol Vis Sci. 2011;52:109-118.
11. Hadziahmetovic M, Song Y, Wolkow N, et al. The oral iron chelator deferiprone protects against iron overload-induced retinal degeneration. Invest Ophthalmol Vis Sci. 2011;52:959-968.
12. Hadziahmetovic M, Song Y, Wolkow N, et al. Bmp6 regulates retinal iron homeostasis and has altered expression in agerelated macular degeneration. Am J Pathol. 2011;179:335-348.
13. Gnana-Prakasam JP, Martin PM, Simth SB, Ganapathy V. Expression and function of iron-regulatory proteins in retina. IUBMB Life. 2010;62:363-370.
14. He X, Hahn P, Iacovelli J, et al. Iron homeostasis and toxicity in retinal degeneration. Prog Retin Eye Res. 2007;26:649-673.
15. Song D, Dunaief JL. Retinal iron homeostasis in health and disease. Front Aging Neurosci. 2013;5:24.
16. Dunaief JL. Iron induced oxidative damage as a potential factor in age-related macular degeneration: the Cogan Lecture. Invest Ophthalmol Vis Sci. 2006;47:4660-4664.
17. Wong RW, Richa DC, Hahn P, Green WR, Dunaief JL. Iron toxicity as a potential factor in AMD. Retina. 2007;27:997-1003.
18. Blasiak J, Szaflik J, Szaflik JP. Implications of altered iron homeostasis for age-related macular degeneration. Front Biosci. 2011;16:1551-1559.
19. Ciudin A, Hernandez C, Simo R. Iron overload in diabetic retinopathy: a cause or a consequence of impaired mechanisms? Exp Diabetes Res. 2010;2010. pii: 714108.
20. Rajpathak SN, Crandall JP, Wylie-Rosett J, Kabat GC, Rohan TE, Hu FB. The role of iron in type 2 diabetes in humans. Biochim Biophys Acta. 2009;1790:671-681.
21. Simcox JA, McClain DA. Iron and diabetes risk. Cell Metab. 2013;17:329-341.
22. Crawford TN, Alfaro DV, Kerrison JB, Jablon EP. Diabetic retinopathy and angiogenesis. Curr Diabetes Rev. 2009;5:8-13.
23. Zhang W, Liu H, Al-Shabrawey M, Caldwell RW, Caldwell RB. Inflammation and diabetic retinal microvascular complications. J Cardiovasc Dis Res. 2011;2:96-103.
24. Chappelow AV, Kaiser PK. Neovascular age-related macular degeneration: potential therapies. Drugs. 2008;68:1029-1036.
25. Bhutto I, Lutty G. Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/ retinal pigment epithelium/Bruch's membrane/choriocapillaris complex. Mol Aspects Med. 2012;33:295-317.
26. Stitt AW, Li YM, Gardiner TA, Bucala R, Archer DB, Vlassara H. Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGEinfused rats. Am J Pathol. 1997;150:523-531.
27. Tawfik A, Al-Shabrawey M, Roon P, et al. Alterations of retinal vasculature in cystathionine-β-synthase mutant mice, a model of hyperhomocysteinemia. Invest Ophthalmol Vis Sci. 2013; 54:939-949.
28. Yang J, Duh EJ, Caldwell RB, Behzadian MA. Antipermeability function of PEDF involves blockade of the MAP kinase/GSK/ beta-catenin signaling pathway and uPAR expression. Invest Ophthalmol Vis Sci. 2010;51:3273-3280.
29. Fonsatti E, Sigalotti L, Arslan P, Altomonte M, Maio M. Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in human malignancies. Curr Cancer Drug Targets. 2003;3:427-432.
30. Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME. Vascular endothelial growth factor in eye disease. Prog Retin Eye Res. 2008;27:331-371.
31. Hernandez MR, Ye H, Roy S. Collagen type IV gene expression in human optic nerve heads with primary open angle glaucoma. Exp Eye Res. 1994;59:41-51.
32. Anik I, Kokturk S, Genc H, et al. Immunohistochemical analysis of TIMP-2 and collagen types I and IV in experimental spinal cord ischemia-reperfusion injury in rats. Spinal Cord Med. 2011;34:257-264.
33. Miller JW, Le Couter J, Strauss EC, Ferrara N. Vascular endothelial growth factor a in intraocular vascular disease. Ophthalmology. 2013;120:106-114.
34. Lewis GP, Fisher SK. Up-regulation of glial fibrillary acidic protein in response to retinal injury: its potential role in glial remodeling and a comparison to vimentin expression. Int Rev Cytol. 2003;230:263-290.
35. Erickson KK, Sundstrom JM, Antonetti DA. Vascular permeability in ocular disease and the role of tight junctions. Angiogenesis. 2007;10:103-117.
36. Meynard D, Babitt JL, Lin HY. The liver: conductor of systemic iron regulation. Blood. 2014;123:168-176.
37. Gnana-Prakasam JP, Martin PM, Mysona BA, Roon P, Smith SB, Ganapathy V. Hepcidin expression in mouse retina and its regulation via lipopolysaccharide/Toll-like receptor-4 pathway independent of Hfe. Biochem J. 2008;411:79-88.
38. Zhou Y, Yan H, Guo M, Zhu J, Xiao Q, Zhang L. Reactive oxygen species in vascular formation and development. Oxid Med Cell Longev. 2013;2013:374963.
39. Myllyharju J. HIF prolyl 4-hydroxylases and their potential as drug targets. Curr Pharm Des. 2009;15:3878-3885.
40. Salnikow K, Kasprzak KS. Ascorbate depletion: a critical step in nickel carcinogenesis? Environ Health Perspect. 2005;113: 577-584.
41. Kim TH, Hur EG, Kang SJ, et al. NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1α. Cancer Res. 2011;71:2260-2275.
42. Grochot-Przeczek A, Kotlinowski J, Kozakowska M, et al. Heme oxygenase-1 is required for angiogenic function of bone marrow-derived progenitor cells: role in therapeutic revascularization. Antioxid Redox Signal. 2014;20:1677-1692.
43. Dulak J, Deshane J, Jozkowicz A, Agarwal A. Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation. 2008;117:231-241.
44. McCrae KR, Donate F, Merkulov S, Sun D, Qi X, Shaw DE. Inhibition of angiogenesis by cleaved high molecular weight kininogen (HKa) and HKa domain 5. Curr Cancer Drug Targets. 2005;5:519-528.
45. Coffman LG, Parsonage D, D'Agostino R Jr, Torti FM, Torti SV. Regulatory effects of ferritin on angiogenesis. Proc Natl Acad Sci U S A. 2009;106:570-575.
46. Sapieha P, Sirinyan M, Hamel D, et al. The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat Med. 2008;14:1067-1076.
47. Cai J, Pardali E, Sanchez-Duffhues G, ten Dijke P. BMP signaling in vascular diseases. FEBS Lett. 2012;586:1993-2002.
48. Beets K, Huylebroeck D, Moya IM, Umans L, Zwijsen A. Robustness in angiogenesis: notch and BMP shaping waves. Trends Genet. 2013;29:140-149.
49. Stirnberg M, Gutschow M. Matriptase-2, a regulatory protease of iron homeostasis: possible substrates, cleavage sites, and inhibitors. Curr Pharm Des. 2013;19:1052-1061.
50. Hahn P, Qian Y, Dentchev T, et al. Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2004;101:13850-13855.